Physician
DR. Miniyars Pediatrics, P.C.
DR. Miniyars Pediatrics, P.C. was paid $18.79M by Medicaid between Jan 2018 and Dec 2024, across 86 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 30% of everything it billed.
33Billing provider infoDR. MINIYARS PEDIATRICS, P.C.
ROME, GA 30165
ROME, GA 30165
33aNPI1760651806assigned 02/22/2008
33bProvider typePediatrics Physician
28Total paid$18.79M
24GClaims424,519
24DCodes billed86
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Georgia
Rank by total paid#3 of 220
Median peer was paid$57K
This provider vs. median328×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 70,998 | $3.02M | |
| 2019 | 76,864 | $3.20M | |
| 2020 | 59,388 | $2.28M | |
| 2021 | 59,907 | $2.69M | |
| 2022 | 64,673 | $3.19M | |
| 2023 | 59,805 | $2.80M | |
| 2024incomplete | 32,884 | $1.63M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 57,061 | 52,022 | $5.57M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 71,157 | 65,809 | $4.59M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 9.2% | 30,574 | 29,172 | $1.73M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.7% | 12,473 | 12,222 | $1.26M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.3% | 12,059 | 11,467 | $1.18M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.6% | 6,145 | 5,956 | $670K |
| 99051 | 3.3% | 23,824 | 22,474 | $612K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.0% | 6,355 | 5,934 | $571K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.4% | 8,631 | 8,336 | $442K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.0% | 9,677 | 9,324 | $378K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 1.4% | 1,575 | 839 | $270K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.4% | 16,668 | 15,800 | $260K |
74 more codes
| 95117 | 1.2% | 11,924 | $227K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 13,311 | $209K |
| 99429 | 1.1% | 13,836 | $205K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 508 | $145K |
| 96127 | <1% | 14,300 | $66K | |
| 99173 | <1% | 23,476 | $57K | |
| D1206 | Topical application of fluoride varnish | <1% | 3,039 | $56K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,464 | $49K |
| 96160 | <1% | 9,658 | $39K | |
| 92551 | <1% | 8,345 | $30K | |
| 87807 | <1% | 1,704 | $27K | |
| 96161 | <1% | 5,386 | $20K | |
| 85018 | <1% | 4,071 | $13K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 553 | $10K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 466 | $9K |
| 90686 | <1% | 3,649 | $8K | |
| G9920 | Screening performed and negative | <1% | 1,049 | $7K |
| 90670 | <1% | 4,980 | $7K | |
| 90713 | <1% | 6,383 | $7K | |
| 83655 | <1% | 617 | $6K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 59 | $6K |
| 0001A | <1% | 133 | $6K | |
| 90671 | <1% | 332 | $5K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 287 | $4K |
| 99381 | <1% | 42 | $4K | |
| 0002A | <1% | 79 | $3K | |
| 94760 | <1% | 445 | $3K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 45 | $3K |
| 2014F | <1% | 308 | $2K | |
| 90716 | <1% | 1,365 | $2K | |
| 91300 | <1% | 290 | $2K | |
| 90651 | <1% | 844 | $2K | |
| 95115 | <1% | 135 | $2K | |
| 99050 | <1% | 86 | $2K | |
| 90707 | <1% | 1,385 | $2K | |
| 90672 | <1% | 318 | $2K | |
| 90744 | <1% | 1,101 | $1K | |
| 0072A | <1% | 34 | $1K | |
| 0071A | <1% | 31 | $1K | |
| 94150 | <1% | 167 | $1K | |
| 81003 | <1% | 414 | $1K | |
| 90633 | <1% | 1,456 | $926.46 | |
| 90649 | <1% | 441 | $880.51 | |
| 99188 | <1% | 36 | $728.28 | |
| 36416 | <1% | 5,986 | $675.03 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 398 | $672.26 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 473 | $664.50 |
| 92588 | <1% | 18 | $559.64 | |
| 86580 | <1% | 60 | $527.45 | |
| 90680 | <1% | 1,590 | $445.51 | |
| 90734 | <1% | 501 | $406.74 | |
| 90621 | <1% | 96 | $400.06 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 149 | $326.50 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 14 | $316.26 |
| 90685 | <1% | 342 | $126.73 | |
| 99408 | <1% | 64 | $120.28 | |
| 86308 | <1% | 15 | $106.78 | |
| 90700 | <1% | 9,224 | $97.94 | |
| 99406 | <1% | 77 | $91.52 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 33 | $57.70 |
| 90715 | <1% | 124 | $50.06 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 1,849 | $36.60 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 43 | $35.10 |
| 90648 | <1% | 5,115 | $32.32 | |
| 3085F | <1% | 158 | $20.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 417 | $11.32 |
| 90619 | 0% | 88 | $0.00 | |
| 99174 | 0% | 118 | $0.00 | |
| 97802 | 0% | 321 | $0.00 | |
| 90647 | 0% | 26 | $0.00 | |
| 90723 | 0% | 15 | $0.00 | |
| 99401 | 0% | 122 | $0.00 | |
| 99072 | 0% | 320 | $0.00 | |
| 90681 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMINIYAR, RAJ (OWNER)